local_hospital

Mech Sense

Address
Moelleparkvej 4, 9000 Aalborg, Denmark

Digestive System Research

At Mech Sense in Aalborg, the Department of Gastroenterology and Hepatology is running clinical research focused on Digestive System Diseases, with an emphasis on conditions that affect comfort, digestion, and quality of life.

  • Research in chronic pancreatitis is exploring ways to reduce pain and improve physical function and daily well-being.
  • Studies on opioid induced bowel dysfunction are examining how bowel activity and digestive movement are affected by opioid use.
  • These trials aim to test new treatment approaches and better understand digestive symptoms using objective clinical assessment.

The site combines patient-centered work on symptom relief with research into how the gastrointestinal tract responds to treatment and medication.

Chronic Pancreatitis Studies

One key area of investigation at this research facility is chronic pancreatitis, where trials are focused on easing persistent pain and supporting better everyday functioning for affected patients.

  • Exploring a potential new therapy for painful chronic pancreatitis.
  • Assessing whether treatment can lower symptom burden and improve quality of life.
  • Advancing care for a long-term digestive disease with significant impact on patients' lives.

This research reflects a broader effort to improve treatment options in gastroenterology through carefully designed clinical studies.

Opioid-Related Bowel Function Research

Another important focus is opioid induced bowel dysfunction, where studies are evaluating how medicines and opioids influence bowel transit, motility, secretion, and colon volume.

  • Testing a treatment approach for opioid-related bowel dysfunction.
  • Studying the digestive effects of tramadol in a controlled research setting.
  • Improving understanding of how opioid use alters gastrointestinal performance.

These trials support better diagnosis and management of medication-related digestive problems in patients treated at Mech Sense.

Site Overview

assignment
3
connected trials
corporate_fare
1
sponsor
science
5
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 111 other sites in Denmark

description
Trial volume
3
Outperforms 55% of sites
public
Therapeutic diversity
1areas
Outperforms 3% of sites
groups
Sponsor diversity
1sponsors
Outperforms 3% of sites

Therapeutic Area Benchmark — Denmark

Select a therapeutic area to compare against other sites in Denmark.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Denmark

Market Share

Country: Denmark

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Mech Sense

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Naldemedine on Opioid-Induced Bowel Dysfunction in Patients Receiving Tramadol: A Randomized, Double-Blind, Placebo-Controlled TrialAalborg University HospitalPhase IIRecruitingAug 2024

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
NALDEMEDINE1Unknown2024-08-122024-08-12

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.